Innate immune recognition controls adaptive immune responses through multiple mechanisms. The MyD88 signaling adaptor operates in many cell types downstream of Toll-like receptors (TLRs) and interleukin-1 (IL-1) receptor family members. Celltype-specific functions of MyD88 signaling remain poorly characterized. Here, we have shown that the T cell-specific ablation of MyD88 in mice impairs not only T helper 17 (Th17) cell responses, but also Th1 cell responses. MyD88 relayed signals of TLRinduced IL-1, which became dispensable for Th1 cell responses in the absence of T regulatory (Treg) cells. Treg cell-specific ablation of MyD88 had no effect, suggesting that IL-1 acts on naive CD4 + T cells instead of Treg cells themselves. Together, these findings demonstrate that IL-1 renders naive CD4 + T cells refractory to Treg cell-mediated suppression in order to allow their differentiation into Th1 cells. In addition, IL-1 was also important for the generation of functional CD4 + memory T cells.
INTRODUCTION
The innate instruction of adaptive immunity is controlled on multiple levels. The activation of pattern recognition receptors (PRRs) such as Toll-like receptors (TLRs) in dendritic cells (DCs) leads to the upregulation of costimulatory molecules and secretion of proinflammatory cytokines. This activation program provides a critical layer in the discrimination between self and non-self and is essential for the activation of T cell responses (Iwasaki and Medzhitov, 2010; Schenten and Medzhitov, 2011) . Despite the progress in the general understanding of the rules that govern the interaction between DCs and cognate CD4 + T cells following TLR activation, the specific roles of individual TLR-induced cytokines and T cell-specific TLR signals in shaping CD4 + T cell responses remain incompletely understood. CD4 + T cells express several TLRs, although the precise patterns of TLR expression in particular CD4 + T cell subsets are still subject to debate (Cairns et al., 2006; Caramalho et al., 2003; Fukata et al., 2008; Gelman et al., 2004; Gonzá lez-Navajas et al., 2010; Kabelitz, 2007) . Multiple studies have demonstrated various effects of TLR stimulation in T cells. For example, the stimulation of CD4 + T cells with TLR9 agonists causes enhanced proliferation, survival, and secretion of interleukin-2 (IL-2) (Gelman et al., 2004) . Similarly, T cell-specific TLR2 activation can enhance the generation of Th17 cell responses (Reynolds et al., 2010) . Some TLRs also appear to influence naturallyoccurring CD4 + CD25 + Treg cells directly by dampening their suppressive capabilities, in part by lowering the expression of FoxP3, the lineage-defining transcription factors of these cells (LaRosa et al., 2007; Liu et al., 2006; Sutmuller et al., 2006) . Thus, TLRs seem to modulate both CD4 + effector T cell and Treg cell responses simultaneously in order to promote the generation of CD4 + T cell responses.
Members of the IL-1 family of cytokines are known to control several aspects of T cell responses directly (Dinarello, 2009; Sims and Smith, 2010) . In recent years, IL-1 has received much attention because of its involvement in the differentiation of Th17 cells. These cells express the IL-1 receptor (IL-1R) and several studies have suggested that IL-1 enhances the differentiation of naive CD4 + T cells into Th17 cells in vitro (Acosta-autoimmune encephalomyelitis (EAE) and colitis (Chung et al., 2009; Fukata et al., 2008; Sutton et al., 2006; Tomita et al., 2008) . In addition to its role in Th17 cell biology, however, it has been suggested that IL-1 plays an important role in the generation of both primary as well as secondary Th1 cell responses (Ben-Sasson et al., 2009; Sims and Smith, 2010) . Some studies detect the IL-1R on naive and Th1 cells, whereas others find no evidence for this (Chung et al., 2009; Guo et al., 2009; TaylorRobinson and Phillips, 1994) . Nonetheless, it seems clear that IL-1 signaling contributes to the generation of Th1 cell responses. For example, it has been suggested to promote the upregulation of the IL-2 receptor a chain (CD25), prevent apoptosis, and enhance Th1 cell expansion (Ben-Sasson et al., 2009; O'Neill, 2008) . Moreover, bone marrow chimeras harboring IL-1R-deficient T cells have reduced numbers of Th1 cells during the course of EAE (Ben-Sasson et al., 2009; Chung et al., 2009) . Therefore, IL-1 plays a role in the generation of both Th1 and Th17 cell responses. In contrast, the IL-1-related cytokine IL-18 seems to be more exclusively linked to the generation of Th1 cell responses because Th1 cells can express high amounts of the IL-18R in a T-bet-dependent fashion. In this regard, the function of IL-18 in Th1 cells might parallel that of IL-1 and IL-33 in Th17 and Th2 cells, respectively, namely to reinforce or stabilize CD4 + T cell lineage commitments (Guo et al., 2009) . Thus, members of the IL-1 family appear to be involved in both the activation of CD4 + T cells and maintaining the subsequent lineage commitment decision. In addition to its effects on the development of specific CD4 + T effector subsets, IL-1 signaling also appears to regulate the interaction between effector T cells and Treg cells. Treg cells express the IL-1R, even though the roles of IL-1 on Treg cell function are not clearly understood (Chaudhry et al., 2009; Mercer et al., 2010) . Nonetheless, IL-1 might influence the function of Treg cells directly by blocking the suppressive function of Treg cells (O'Sullivan et al., 2006) . Treg cells are also thought to deprive CD4 + effector T cells of IL-1 (Chaudhry et al., 2009) . Moreover, IL-1 has been implicated enabling the conversion of induced Treg cells into Th17 cells (Chung et al., 2009) . Despite this progress in the understanding of TLR and IL-1 biology, the T cell-specific function of these signals are still incompletely understood, in part due to the pleiotropic nature of these triggers. In this study, we sought to investigate the T cell-specific roles of TLRs, IL-1, and IL-18 on the generation of CD4 + T cell responses in vivo. We report on the generation and analysis of mice carrying a T cell-specific ablation of Myd88, the essential signaling adaptor of most TLRs and receptors of the IL-1 family. Our study identifies a function for IL-1 in rendering CD4 + T cells refractory to Treg cell-mediated suppression. In addition, we show that IL-1 is also necessary to generate functional Th1 memory cells.
RESULTS

T Cell-Specific MyD88 Signaling Is Required for the Induction of Both Th1 and Th17 Cell Responses
In order to investigate the T cell-specific function of signals induced by TLRs and IL-1 family members, we generated mice carrying a T cell-specific ablation of MyD88. We flanked exons 3-5 of the Myd88 gene with loxP sites to allow its deletion by Cre-mediated recombination. These exons encode the essential Toll-IL-1 receptor (TIR) domain of MyD88. Moreover, splicing from exon 2 to exon 6 resulted in a frameshift mutation. The targeting strategy and generation of the mice is outlined in Figures S1A-S1C Figures S4A and S4B ). Because dying cells, such as irradiated splenocytes, might have been a source of IL-1 in the T cell cultures and thus might have affected the experimental outcome during the in vitro phase of the assay, we controlled for the presence of IL-1 in the cultures. We could detect IL-1a and IL-1b in cultured macrophages after stimulation with LPS and ATP, but failed to do so in the T cell assays after restimulation with OVA, even in the presence of a 4-fold higher number of irradiated splenocytes ( Figure S2B ). Indeed, CD4 + T cells from
Myd88
FL/FL Cd4-cre mice also failed to expand and secrete IFN-g after restimulation in the presence of irradiated APCs from Caspase-1-deficient mice, which are impaired in their ability to secrete IL-1 ( Figures S2C and S2D (Moon et al., 2007) . Upon immunization with 2W peptide, the Th1 cell response in Myd88 FL/FL Cd4-cre mice was also impaired, suggesting that the choice of antigen does not influence the outcome of the T cell response as measured by restimulation ( Figure 1C Figure 2A ). CD4 + T cells from these mice also did not display an increased tendency to undergo apoptosis ( Figure 2B ). However, antigen-specific 2W + CD4
+ T cells of Myd88 FL/FL Cd4-cre mice expressed lower amounts of T-bet, the lineage-defining transcription factor of Th1 cells, when compared to WT control cells ( Figure 2C ). Together, our findings therefore demonstrate that T cell-specific MyD88 signaling is required for the generation of functionally competent Th1 cells, even though the initial expansion of the antigen-specific CD4 + T cells is not compromised.
Impaired CD4 + T Cell Response in Myd88
FL/FL Cd4-cre Mice Is Caused by Defective IL-1 Signaling MyD88 relays signals from most TLRs and also from members of the IL-1 family. In order to distinguish between these two We obtained similar results for bone marrow chimeras that carried either a TLR9-or IL-1R-deficient T cell compartment, which we had immunized with OVA and CpG DNA in IFA. We noticed in some, but not all, experiments a moderate contribution of TLR9 signaling to the response, consistent with the suggested role of T cell-intrinsic TLR9 signaling in the generation of CD4 + T cell responses (Gelman et al., 2004) . However, IL-1 signaling was also required under these conditions ( Figures S3C-S3F) . Thus, our results collectively demonstrate that the defective CD4 + T cell response in Myd88
Cd4-cre mice is caused by the inability of the T cells to recognize IL-1 signals, whereas TLR-driven signals play a minor role.
IL-1 Signaling Is Required to Render CD4 + T Cells
Refractory to Treg Cell-Mediated Suppression We had previously shown that transient depletion of regulatory T (Treg) cells in complete MyD88-deficient mice is able to restore the Th1 cell response (Pasare and Medzhitov, 2004 
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Myd88 FL/FL Cd4-cre mice ( Figure 5A) . Similarly, the frequency of Treg cells was also not altered in Myd88 FL/FL Cd4-cre mice after immunization with OVA and LPS in IFA and subsequent restimulation in vitro ( Figure 5B ). In order to measure the frequency of Treg cells more directly, we also analyzed their presence in the draining lymph nodes of immunized mice. Although we noticed a modest tendency of a higher frequency of Treg cells in the draining lymph nodes of some immunized Myd88 FL/FL Cd4-cre mice, we did not detect consistent differences between these mice and WT controls ( Figure 5C 
Cd4-cre and Il6ra
FL/FL Cd4-cre mice were not only distinct from that of WT controls but also different from each other (Figure 7B) . We therefore conclude that IL-1 and IL-6 regulate different processes that are both required for an optimal CD4 + T cell response.
DISCUSSION
Here, we have shown that T cell-intrinsic MyD88 activation delivers an important signal for the induction of CD4 + T cell responses in vivo. While T cell-specific TLR2 signaling can augment the generation of Th17 cell responses (Reynolds et al., 2010) , we did not observe a major role for T cell-specific TLR4 or TLR9 activation in the generation of either Th1 or Th17 cell responses, at least not under the conditions used in our experiments. We also did not observe an impact of IL-18 signaling on the generation of the CD4 + T cell response. Consistent with this, we found that the expression of the IL-18 receptor is reduced in antigen-specific CD4 + T cells after immunization.
IL-18 is usually seen as a cytokine that promotes Th1 cell responses. However, Th1 cell responses do not universally depend on this cytokine because Th1 cells can be generated in absence of IL-18 signaling in certain experimental settings (Haring and Harty, 2009; Su et al., 2005) . Instead, we found that the impairment of the CD4 + T cell response in Myd88
Cd4-cre mice was due to the lack of IL-1 signaling. The role of IL-1 in the differentiation of Th17 cells has been appreciated in recent years and our results confirm the central role for this cytokine in the generation of this T cell subset. Importantly, however, we found that IL-1 also plays an important role in the induction of Th1 cell responses. MyD88 and, by extension, TLR activation in T cells had been previously suggested to deliver a survival signal to CD4 + T cells, in part via the upregulation of BCL XL (Gelman et al., 2006; Rahman et al., 2008) . Likewise, IL-1 had also been implicated in the provision of a survival signal to CD4 + T cells (Ben-Sasson et al., 2009 ). The absence of such a signal could have explained the phenotype that we observed in Myd88
Cd4-cre mice. However, antigen-specific MyD88-deficient CD4 + T cells proliferated normally and did not exhibit an increased tendency to undergo apoptosis. Consistent with this 
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MyD88 Signaling in CD4 + T Cells Blocks Treg Cells observation, antigen-specific CD4 + T cells were present at a similar frequency in Myd88 FL/FL Cd4-cre mice as in WT controls.
Thus, the provision of a survival signal per se is unlikely to be a major function of IL-1 in this context. Instead, we could restore the Th1 cell response in Myd88
Cd4-cre mice in the absence of Treg cells, while the Th17 cell response remained defective, presumably because of the additional requirement of IL-1 for the differentiation of Th17 cells. IL-1 signaling had been previously suggested to compromise the suppressive capability of Treg cells (Mercer et al., 2010; O'Sullivan et al., 2006) . The normal CD4 + T cell response in Myd88 FL/FL Foxp3-cre mice suggests that this was not the case and points toward a function for IL-1 in either the naive or effector CD4 + T cell compartment. The reciprocal relationship between developing Th17 cells and Treg cells can lead to an increase in iTreg cells in the absence of the former cells. This is the case in mice that are deficient in IL-6 signaling, at least under some conditions (Bettelli et al., 2006; Korn et al., 2008) . A similar function has also been suggested for IL-1 (Chung et al., 2009 T cells were impaired in their ability to differentiate into IFN-gsecreting T cells after secondary immunization, even under conditions where Treg cells were absent during both the primary and secondary immunization. In the context of a Th1 cell response, the IL-1 signal seems therefore to carry additional information that goes beyond the release of naive or effector CD4 + T cells from Treg cell-mediated suppression. One possibility could be that during the primary immunization, CD4 + T cells fail to fully differentiate into memory CD4 + T cells and thus are present after the primary immunization in a functionally compromised state. Alternatively, the requirement for IL-1 signaling during a secondary Th1 cell response even in the absence of Treg cells might reflect activation requirements that are unique for memory CD4 + T cells. Indeed, it has been suggested that the expansion of memory CD4 + T cells is sensitive to IL-1 signaling after secondary challenge with antigen (Luqman et al., 1992) . This aspect might be an intrinsic feature of memory CD4 + T cells that is independent of their control by Treg cells and might thus explain the lack of a memory CD4 + T cell response in Myd88 FL/FL Cd4-cre mice even after transient depletion of Treg cells during the secondary challenge. Further experiments will be necessary to distinguish between these possibilities. Our study has addressed the function of CD4 + T cell-specific
MyD88 signaling in the context of immunizations by using TLR ligands as adjuvants. IL-1 induced under these conditions was required for the induction of a Th1 cell response. However, it is certainly possible that other cytokines or membrane-bound signals carry similar information and are also releasing CD4 + T cell from Treg cell-mediated suppression, particularly as a consequence of the activation of other PRR systems. In this regard, it is interesting to note that IL-4 and IL-15 have been proposed to operate in this manner (Ben Ahmed et al., 2009; Thornton et al., 2004) . Thus, cytokines induced by different types of infections might function in a way analogous to IL-1 by making naive or effector T cells refractory to Treg cell-mediated suppression. Therefore, it remains to be seen to what extent IL-1 is required to overcome Treg cell-mediated suppression upon live infections. IL-6 had been previously implicated in the release of CD4 + T cells from Treg cell-mediated suppression (Pasare and Medzhitov, 2003) . The observation that Myd88 FL/FL Cd4-cre and
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FL/FL Cd4-cre mice share a similar overall phenotype supports the notion that that IL-1 and IL-6 both cooperate in this process in vivo (S.A.N., D.S., and R.M., unpublished data). IL-6 has been reported to induce the expression of the IL-1R on CD4 + T cells (Chung et al., 2009 
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FL/FL Cd4-cre mice revealed little overlap in the differentially expressed genes. It therefore seems more likely that IL-1 and IL-6 integrate different aspects of the immunological challenge. This notion is particularly interesting in light of the unique mechanism involved in IL-1 secretion, namely the requirement for inflammasome activation (Strowig et al., 2012) . Inflammasome activation requires both a TLR signal and a second signal that can be triggered by microbial virulence activities (Brodsky and Monack, 2009 ). Thus, IL-1 can ''report'' microbial virulence activity to CD4 + T cells (Brodsky et al., 2010) . IL-1 also signals the presence of live infections, at least under some circumstances (Sander et al., 2011) . The critical role of IL-1 in CD4 + T cell responses might therefore reflect its unique expression requirements: while TLR activation reports on microbial origin of antigens, IL-1 expression might indicate the nature or the status of microbial threat (live versus dead, innocuous versus virulent). While antigen origin can be either microbial or not, virulence is a graded function (pathogen can be more or less virulent) as is the viability at the level of a microbial population. Interestingly, CD4 + T cell susceptibility to Treg cell-mediated suppression also appears to be a graded phenomenon and can be shifted in either direction by varying the conditions of T cell activation (Shevach, 2009 (Rubtsov et al., 2008) . Il1r À/À mice, Il18r À/À mice, and Tcrb À/À and Tcrd À/À compound mutant mice were purchased from the Jackson Laboratory (Glaccum et al., 1997; Hoshino et al., 1999) . Tlr9 À/À mice and Tlr2 À/À and Tlr4 À/À compound mutant mice were maintained at the Yale School of Medicine. All mice were kept on a C57BL/6 genetic background. The mice were housed in the Yale Animal Resources Center (YARC) and the experiments were done with approval by the Yale University Institutional Animal Care and Use Committee (IACUC).
Immunizations
The mice were immunized in both feet with either 100 mg/mouse OVA (Sigma) or 100 mg/mouse 2W1S peptide (EAWGALANWAVDSA, Genscript) plus 10 mg/mouse LPS (Sigma) emulsified in incomplete Freund's adjuvant (Sigma).
For some experiments, LPS was replaced with either 20 mg/mouse CpG DNA 1826 (Keck Biotechnology Resource Laboratory, Yale Medical School), 50 mg/mouse polyI:C (Invivogen), 20 mg/mouse Peptidoglycan (Invivogen), or 150 mg/mouse heat-inactivated M. tuberculosis (Sigma). The effects of contaminating endotoxin in the OVA preparations were controlled by using endotoxin-free OVA (Hyglos/Biovendor) in key experiments. CD4 + memory responses were induced similarly with the exception that one foot was used for the primary immunization, while the other foot was used for the secondary immunization 30-60 days later.
Antibodies and Other Reagents
All standard antibodies for flow cytometry were purchased from either BD Biosciences or Ebiosciences. FITC-PNA was purchased from Biovector, and the a-activated caspase-3 antibody was obtained from R&D Systems. PE-conjugated 2W:I-A b tetramers were a gift from Marc Jenkins (University of Minnesota). Bromodeoxyuridine (BrdU) incorporation was measured with the BrdU staining kit from BD Bioscences. The a-CD25 antibody PC61 was purified from hybridoma cells adapted to serum-free medium and grown in Cellline 2-compartment bioreactors (BD Biosciences). MyD88 protein was detected by immunoblotting with a goat a-MyD88 antibody (R&D Systems).
T Cell Assay CD4 + T cells were isolated from the popliteal and inguinal lymph nodes 7 days after immunization by magnetic cell sorting with aCD4 beads (Miltenyi Biotech). The cells were seeded in round-bottom 96-well plates at a concentration of 100,000 cells per well in the presence of 300,000 irradiated splenocytes in the presence of serial dilutions of OVA, starting at 900 mg/ml. Proliferation was measured on day 4 following the addition of 3 H-thymidine for the last 24 hr and the secretion of IFN-g and IL-17 was measured by ELISA or intracellular flow cytometry.
Treg Cell Depletion
Treg cells were depleted in vivo with 150 mg/mouse of an aCD25 antibody (clone PC61) by intravenous injection 3 days prior to immunization. Depletion of Treg cells was confirmed on the day of immunization by flow cytometry upon staining of CD4 + T cells from the blood with an aCD25 antibody (clone 7D4).
Bone Marrow Chimeras
Bone marrow from Tcrb À/À and Tcrd À/À compound mutant mice was mixed in a ratio of 3:1 with bone marrow isolated from C57BL/6 WT mice, Il1r À/À mice,
Il18r
À/À mice, Tlr9 À/À mice, or Tlr2 À/À and Tlr4 À/À compound mutant mice.
We injected 10 3 10 6 total cells per mouse into Rag2 À/À mice that had been lethally irradiated with 900 rad 1 day prior to the bone marrow transfer. The reconstitution of the hematopoetic system was confirmed after 6 weeks by flow cytometry.
RNA-Seq
Antigen-specific CD4 + T cells were isolated by flow cytometry from a total of 15-20 immunized mice per genotype. RNA was isolated from approximately 100,000 cells per genotype with the RNeasy isolation kit (QIAGEN) and processed and sequenced by the Yale Center for Genome Analysis (YCGA).
Statistical Analysis
Data were analyzed with a Student's t test with Prism4 (Graphpad Software). In case with abnormal distribution, the data were also analyzed with a MannWhitney test using the same software. Unless not mentioned specifically, data are shown as mean ± SD. p values: *, p % 0.05; **, p % 0.005; ***, p % 0.0005; n.s., not significant. PCA analysis of gene-expression data was performed with R (2.15.3).
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